The Valley Desk

NCT03132675 · Interventional trial

Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab Treatment

Overall registry status Unknown

Phase 2

Conditions Stage III/IV Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov